Skip to main content

Table 3 Relapse-Free Survival: Univariate and Multivariate Analyses for All Patients (N = 46)

From: Histone H4 acetylation by immunohistochemistry and prognosis in newly diagnosed adult acute lymphoblastic leukemia (ALL) patients

Patient Characteristic HR on Univariate Analysis (95% confidence interval with p-value) HR on Multivariate Analysis (95% confidence interval with p-value)
Histone acetylation (Positive versus negative) 0.42 (0.16-1.13), p = 0.09 0.55 (0.19-1.59), p = 0.27
Age (>35 years vs. ≤35 years) 1.81 (0.75-4.34), p = 0.19 1.39 (0.35-5.72), p =0 .65
White blood count (>20,000/μL versus ≤20,000/μL) 3.88 (1.54-9.79), p = 0.004 15.0 (2.41-89.5), p = 0.003
Poor risk cytogenetics versus others 2.36 (0.93-6.03), p = 0.07